Biogen (Italian Wikipedia)

Sanofi to Acquire Bioverativ for $11.6 Billion, su globenewswire.com, 22 gennaio 2018. URL consultato il 31 gennaio 2025 (archiviato dall'url originale il 23 gennaio 2018). Ospitato su Sanofi.
Sudip Kar-Gupta, Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion, su reuters.com, Reuters, 22 gennaio 2018. URL consultato il 31 gennaio 2025 (archiviato dall'url originale il 31 gennaio 2025).
Sanofi buys US haemophilia treatment firm for $11.6 bn, su france24.com, Parigi, AFP, 22 gennaio 2018. URL consultato il 31 gennaio 2025 (archiviato dall'url originale il 9 novembre 2020).
Sanofi Completes Acquisition of Bioverativ Inc.- Bioverativ Inc. is a fully owned subsidiary of Sanofi, su sec.gov, Paris, 8 marzo 2018 (archiviato dall'url originale il 31 gennaio 2025).

archive.today (Global: 14^th place; Italian: 11^th place)

Biogen Idec's PLEGRIDY(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis, su reuters.com, Reuters. URL consultato il 30 giugno 2017 (archiviato dall'url originale il 16 settembre 2014).
Biogen Sees Eloctate FDA Delay Pushing Marketing to Mid-2014, su businessweek.com, BusinessWeek. URL consultato l'11 dicembre 2013 (archiviato dall'url originale il 26 luglio 2014).

biogen.com (Global: low place; Italian: low place)

investors.biogen.com

2018 Annual Report, su investors.biogen.com, biogen.com. URL consultato il 17 marzo 2022.
2019 Annual Report, su investors.biogen.com, biogen.com. URL consultato il 17 marzo 2022.
2020 Annual Report, su investors.biogen.com, biogen.com. URL consultato il 18 marzo 2022.

media.biogen.com

(EN) IMRALDI™, Biogen's Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union | Biogen, su media.biogen.com. URL consultato il 7 giugno 2021.

biopharmadive.com (Global: low place; Italian: low place)

(EN) Biogen submitted its Alzheimer's drug for approval. Now what?, su BioPharma Dive. URL consultato il 29 luglio 2020.

bioprocessintl.com (Global: low place; Italian: low place)

(EN) Biogen bulking out mAb pipeline through $1.15bn HI-Bio buy, su bioprocessintl.com. URL consultato il 23 maggio 2024.

biospace.com (Global: low place; Italian: low place)

(EN) Biogen and Sangamo Ink $2.7 Billion+ Neurodegeneration Deal, su BioSpace, 28 febbraio 2020. URL consultato il 28 febbraio 2020.
BIOGEN ANNOUNCES AGREEMENT TO ACQUIRE NIGHTSTAR THERAPEUTICS TO ESTABLISH CLINICAL PIPELINE OF GENE THERAPY CANDIDATES IN OPHTHALMOLOGY, su BioSpace, 4 marzo 2019. URL consultato il 2 giugno 2019.
Biogen Banks on Ophthalmology Gene Therapies With $800 Million Acquisition of Nightstar, su BioSpace, 4 marzo 2019. URL consultato il 2 giugno 2019.

bloomberg.com (Global: 99^th place; Italian: 274^th place)

Biogen Inc, su Bloomberg.
Biogen to Pay Elan $3.25 Billion for Full Tysabri Rights, in Bloomberg, 6 febbraio 2013. URL consultato il 28 dicembre 2017.

boston25news.com (Global: low place; Italian: low place)

(EN) Live updates: Multiple Mass. schools closed Monday after 15 new presumptive positive COVID-19 cases reported, su WFXT. URL consultato il 9 marzo 2020.

bostonglobe.com (Global: 553^rd place; Italian: 1,614^th place)

Timothy Annett, Biogen shares plunge after Alzheimer's drug setback, in The Boston Globe, 21 marzo 2019. URL consultato il 2 giugno 2019.
Biogen unveils name for hemophilia drug spinoff: Bioverativ, in Boston Globe.
Biogen pays $900m to settle whistle-blower suit over kickbacks, su bostonglobe.com.

businessinsider.com (Global: 140^th place; Italian: 340^th place)

Biogen is cutting 11% of its workforce, su Business Insider.

businesswire.com (Global: 615^th place; Italian: 1,092^nd place)

(EN) Biogen Idec to Acquire Fumapharm AG; Consolidates Ownership of Oral Compound BG-12 Being Studied for Multiple Sclerosis, su Businesswire. URL consultato il 28 dicembre 2017.
(EN) Biogen Idec to Acquire Syntonix, su Businesswire. URL consultato il 28 dicembre 2017.
(EN) Biogen Enrolls First Patient in Global Phase 3 Study of Investigational Treatment Aducanumab (BIIB037) for Early Alzheimer's Disease, su businesswire.com, 8 settembre 2015. URL consultato l'11 settembre 2021.
(EN) Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company | Business Wire, su Businesswire. URL consultato il 28 dicembre 2017.

cbslocal.com (Global: 680^th place; Italian: 1,804^th place)

boston.cbslocal.com

(EN) Biogen Conference May Be Tied To 20,000 Massachusetts Coronavirus Cases, su CBS Boston, 25 agosto 2020. URL consultato il 25 agosto 2020.

centerforbiosimilars.com (Global: low place; Italian: low place)

FDA Approves Adalimumab Biosimilar, Samsung Bioepis' Hadlima, su The Center For Biosimilars, 24 luglio 2019. URL consultato il 7 giugno 2021.

cnbc.com (Global: 220^th place; Italian: 646^th place)

Yun Li, Biogen posts its the worst day in 14 years after ending trial for blockbuster Alzheimer's drug, su CNBC, 21 marzo 2019. URL consultato il 2 giugni 2019.
(EN) Berkeley Jr. Lovelace, Biogen stock falls after FDA calls for federal investigation into Alzheimer's drug approval, su CNBC, 9 luglio 2021. URL consultato il 22 marzo 2022.
Yun Li, Biogen shares plunge nearly 30% after ending trial for Alzheimer's drug Aducanumab, CNBC, 21 marzo 2019.

cnn.com (Global: 28^th place; Italian: 84^th place)

Jacqueline Howard e Jamie Gumbrecht, Drugmaker to seek approval for Alzheimer's treatment, su CNN, 22 ottobre 2019. URL consultato il 23 ottobre 2019.

doi.org (Global: 2^nd place; Italian: 7^th place)

dx.doi.org

Meredith Wadman, Updated: FDA approves drug that rescues babies with fatal neurodegenerative disease, in Science, 23 dicembre 2016, DOI:10.1126/science.aal0476.

fda.gov (Global: 447^th place; Italian: 644^th place)

fda.gov

(EN) Office of the Commissioner, FDA Grants Accelerated Approval for Alzheimer's Drug, su FDA, 7 giugno 2021. URL consultato il 22 marzo 2022.
FDA approves Gazyva for chronic lymphocytic leukemia, su fda.gov, FDA. URL consultato l'11 gennaio 2013.
FDA approves Rituxan to treat two rare disorders, su fda.gov, FDA. URL consultato il 19 aprile 2011.
FDA Grants Accelerated Approval for Alzheimer's Drug, su fda.gov, US Food & Drug Administration, 7 giugno 2021. URL consultato il 7 giugno 2021.

accessdata.fda.gov

ADUHELMTM (aducanumab-avwa) injection, for intravenous use, prescribing Information (PDF), su accessdata.fda.gov, FDA.gov. URL consultato il 9 giugno 2021.

fiercebiotech.com (Global: low place; Italian: low place)

(EN) Biogen to buy Syntonix in $120M deal - FierceBiotech, su Fierce Biotech, 3 gennaio 2007. URL consultato il 28 dicembre 2017.
Once-monthly MS drug from Biogen Idec, AbbVie clears Phase III hurdle, su fiercebiotech.com, Fierce Biotech. URL consultato l'8 aprile 2013.
Isis Pharmaceuticals and Biogen Idec, su fiercebiotech.com, Fierce Biotech.

fiercehealthcare.com (Global: low place; Italian: low place)

(EN) Robert King, Major insurers won't pay for Biogen's Alzheimer's drug until they get more proof that it works: Bloomberg survey, su Fierce Healthcare, 22 novembre 2021. URL consultato il 22 marzo 2022.

fiercepharma.com (Global: low place; Italian: low place)

Kyle Blankenship (7 maggio 2020). "Biogen gears up Swiss manufacturing facility for potential aducanumab rollout" Fierce Pharma (Manufacturing). Accesso del 9 giugno 2021.
(EN) Angus Liu, For Biogen's Aduhelm, narrow coverage from CMS 'could effectively spell the end': analyst, su Fierce Pharma, 12 gennaio 2022. URL consultato il 22 marzo 2022.
Amid takeover chatter, Biogen introduces hemophilia spinoff Bioverativ - FiercePharma, su fiercepharma.com, 10 agosto 2016.

firstwordpharma.com (Global: low place; Italian: low place)

Biogen Idec enters deal to acquire Fumapharm, su firstwordpharma.com, First Word Pharma. URL consultato il 31 maggio 2006.

fool.com (Global: 4,183^rd place; Italian: 4,832^nd place)

Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy?, su fool.com, The Motley Fool, 7 aprile 2014. URL consultato il 4 luglio 2014.

forbes.com (Global: 54^th place; Italian: 97^th place)

Biotech's Comeback Kid, in Forbes. URL consultato il 4 dicembre 2012.

ft.com (Global: 210^th place; Italian: 438^th place)

markets.ft.com

Biogen Sets Industry Record with Recognition on Dow Jones Sustainability World Index for 9th Consecutive Year – Company Announcement, su Financial Times, 15 novembre 2021. URL consultato il 9 settembre 2024.

genengnews.com (Global: low place; Italian: low place)

Biogen Idec Snaps Up Convergence for Up-to-$675M - GEN News Highlights - GEN, su genengnews.com, 12 gennaio 2015.

go.com (Global: 48^th place; Italian: 166^th place)

abcnews.go.com

(EN) Health Highlights: August 1, 2008, su ABC News. URL consultato l'11 settembre 2021.
(EN) Biogen will stop selling its controversial Alzheimer's drug Aduhelm, su ABC News. URL consultato il 1º febbraio 2024.

ionispharma.com (Global: low place; Italian: low place)

ir.ionispharma.com

(EN) Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders - Ionis Pharmaceuticals, Inc., su ir.ionispharma.com. URL consultato il 5 ottobre 2021.

macrotrends.net (Global: 5,641^st place; Italian: 6,632^nd place)

Biogen Revenue 2006-2018 | BIIB, su Macro Trends. URL consultato il 5 novembre 2018.

miamitimesonline.com (Global: low place; Italian: low place)

(EN) Staff Report, Biotech company partners with Black-owned bank, su The Miami Times, 9 settembre 2020. URL consultato il 13 settembre 2020.

mstrust.org.uk (Global: low place; Italian: low place)

Fampridine (Fampyra), su mstrust.org.uk, MS Trust.

multiple-sclerosis-research.blogspot.com (Global: low place; Italian: low place)

Lingo: a promising remyelination target in MS, su multiple-sclerosis-research.blogspot.com, Multiple Sclerosis Research. URL consultato il 16 giugno 2014.

nasdaq.com (Global: 2,740^th place; Italian: 3,855^th place)

Biogen Idec Inc. Stock Quote & Summary Data, su nasdaq.com, NASDAQ.

nationalmssociety.org (Global: low place; Italian: low place)

Avonex, su nationalmssociety.org, National MS Society.
Tecifedra, su nationalmssociety.org, National MS Society.
Tysabri, su nationalmssociety.org, National MS Society.

nbcboston.com (Global: low place; Italian: 5,570^th place)

(EN) 3 Who Attended Biogen Meeting in Boston Test Positive for Coronavirus, su NBC Boston, 5 marzo 2020. URL consultato il 9 marzo 2020.
(EN) Coronavirus Cases Linked to Biogen Boston Meeting: What We Know, su NBC Boston, 6 marzo 2020. URL consultato il 9 marzo 2020.

nobelprize.org (Global: 301^st place; Italian: 270^th place)

Walter Gilbert, su Nobel Prize. URL consultato il 3 giugno 2024.
Phillip A. Sharp, su Nobel Prize. URL consultato il 3 giugno 2024.

nytimes.com (Global: 7^th place; Italian: 19^th place)

Andrew Pollack, Idec to Merge With Biogen in $6.8 Billion Deal, in New York Times, 24 giugno 2003. URL consultato il 24 giugno 2003.
(EN) Katie Thomas, Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval, in The New York Times, 31 dicembre 2016. URL consultato il 28 febbraio 2022.
(EN) Pam Belluck, Sheila Kaplan e Rebecca Robbins, How an Unproven Alzheimer's Drug Got Approved, in The New York Times, 20 luglio 2021, ISSN 0362-4331 (WC · ACNP). URL consultato il 22 marzo 2022.
Pam Belluck: F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug. New York Times, 6 novembre 2020. Accesso del 20 gennaio 2021.

nzz.ch (Global: 687^th place; Italian: 2,894^th place)

Werner Grundlehner: Zürcher Antikörper gegen Alzheimer hat Milliardenpotenzial – und Gegenwind. Neue Zürcher Zeitung, 8 giugno 2021.

pharmatimes.com (Global: low place; Italian: low place)

(EN) Biogen Idec agrees to buy Swiss company Fumapharm, su Pharma Times, 1º giugno 2006. URL consultato il 28 dicembre 2017.

reuters.com (Global: 49^th place; Italian: 129^th place)

(EN) Manas Mishra, Bhanvi Satija e Bhanvi Satija, Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio, in Reuters, 28 luglio 2023. URL consultato il 28 luglio 2023.
(EN) Ransdell Pierson, Biogen plans late-stage Alzheimer's trial, shares rise, in Reuters, 2 dicembre 2014. URL consultato l'11 settembre 2021.
(EN) Bill Berkrot, Biogen's Alzheimer's drug slows mental decline in early study, in Reuters, 20 marzo 2015. URL consultato l'11 settembre 2021.
(EN) Julie Steenhuysen e Deena Beasley, U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients, in Reuters, 8 giugno 2021. URL consultato l'11 ottobre 2021.
D'Souza, Savio, Biogen to spin off hemophilia drug business into a public company, in Reuters, 3 maggio 2016. URL consultato il 3 maggio 2016.
Companies in Alzheimer's race after US nod for Eisai/Biogen drug, su Reuters.

sciencemag.org (Global: 857^th place; Italian: 540^th place)

Meredith Wadman, Updated: FDA approves drug that rescues babies with fatal neurodegenerative disease, in Science, 23 dicembre 2016, DOI:10.1126/science.aal0476.

sec.gov (Global: 572^nd place; Italian: 1,269^th place)

Biogen and IDEC Pharmaceuticals Announce Merger To Create a New Biotechnology Industry Leader, su Exhibit 99.1. URL consultato il 1º dicembre 2018.
«IDEC — Founded in 1985 to develop monoclonal antibodies. Founders include Ivor Royston, Howard Birndorf, Richard Miller and Brook Byers»

statista.com (Global: 776^th place; Italian: 1,107^th place)

Biogen's revenue from 2007 to 2023, su statista.com. URL consultato il 23 maggio 2024.

statnews.com (Global: 8,771^st place; Italian: low place)

(EN) Biogen puzzles Wall Street with plans to spin off its hemophilia business, su STAT, 3 maggio 2016. URL consultato il 5 ottobre 2021.
(EN) Top Biogen execs were at meeting where attendees had Covid-19, su STAT, 6 marzo 2020. URL consultato il 9 marzo 2020.

thepharmaletter.com (Global: low place; Italian: low place)

Biogen Idec's Eloctate gains FDA approval, su thepharmaletter.com, The Pharma Letter. URL consultato il 6 settembre 2014.
Biogen Idec's Plegridy approved in Europe for relapsing-remitting multiple sclerosis, su thepharmaletter.com, The Pharma Letter.
Cell Therapeutics buys Zevalin from Biogen Idec for $10M, with up to $20M extra plus milestones, su thepharmaletter.com, The Pharma Letter. URL consultato il 3 settembre 2007.

tmx.com (Global: low place; Italian: low place)

money.tmx.com

TMX Money, su money.tmx.com. URL consultato il 5 ottobre 2021.

uci.edu (Global: 3,063^rd place; Italian: 5,968^th place)

mind.uci.edu

(EN) Kirsten, Investigational antibody treatment yields exciting though preliminary results - UCI MIND, su mind.uci.edu. URL consultato l'11 ottobre 2021.
(EN) Kirsten, Phase 3 Trials of Aducanumab Halted - UCI MIND, su mind.uci.edu. URL consultato l'11 ottobre 2021.

ucsd.edu (Global: 1,933^rd place; Italian: 4,694^th place)

libraries.ucsd.edu

The San Diego Technology Archive, su libraries.ucsd.edu.

unibo.it (Global: 4,963^rd place; Italian: 325^th place)

acnpsearch.unibo.it

(EN) Pam Belluck, Sheila Kaplan e Rebecca Robbins, How an Unproven Alzheimer's Drug Got Approved, in The New York Times, 20 luglio 2021, ISSN 0362-4331 (WC · ACNP). URL consultato il 22 marzo 2022.
Charley Grant, Surprise Drug Approval Is Holiday Gift for Biogen, in Wall Street Journal, 27 dicembre 2016, ISSN 0099-9660 (WC · ACNP). URL consultato il 27 dicembre 2016.

wbur.org (Global: 2,911^th place; Italian: low place)

(EN) Genetic 'Fingerprints' Suggest Superspreader Biogen Conference Seeded 40% Of Boston Coronavirus Cases, su wbur.org, 25 agosto 2020. URL consultato il 27 settembre 2021.

wcvb.com (Global: low place; Italian: low place)

(EN) Workers who attended Boston Biogen meeting test positive for coronavirus, su WCVB, 6 marzo 2020. URL consultato il 9 marzo 2020.

web.archive.org (Global: 1^st place; Italian: 1^st place)

Reuters, su uk.reuters.com (archiviato dall'url originale il 27 novembre 2020).
(EN) Kirsten, Biogen and Eisai submit aducanumab for FDA approval - UCI MIND, su 128.200.55.17. URL consultato l'11 ottobre 2021 (archiviato dall'url originale il 4 luglio 2021).
Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company - Biogen Media, su media.biogen.com. URL consultato l'11 agosto 2016 (archiviato dall'url originale il 13 agosto 2016).
(EN) Fortune 500 Companies 2021: Who Made the List, su Fortune. URL consultato l'8 febbraio 2022 (archiviato dall'url originale il 10 novembre 2018).
FDA Approval for Rituximab, su cancer.gov, National Cancer Institute. URL consultato il 31 gennaio 2025 (archiviato dall'url originale il 6 aprile 2015).
UPDATE 1-Roche, Biogen end dispute over Rituxan follow-ons, in Reuters, 21 ottobre 2010. URL consultato il 21 ottobre 2010 (archiviato dall'url originale il 27 luglio 2014).
David Holley, Biogen Offers Up To $1 Billion for AGTC's Ophthalmology Gene Therapy, in Xconomy Boston, 2 luglio 2015 (archiviato dall'url originale il 3 luglio 2015).

worldcat.org (Global: 5^th place; Italian: 26^th place)

(EN) Pam Belluck, Sheila Kaplan e Rebecca Robbins, How an Unproven Alzheimer's Drug Got Approved, in The New York Times, 20 luglio 2021, ISSN 0362-4331 (WC · ACNP). URL consultato il 22 marzo 2022.
Charley Grant, Surprise Drug Approval Is Holiday Gift for Biogen, in Wall Street Journal, 27 dicembre 2016, ISSN 0099-9660 (WC · ACNP). URL consultato il 27 dicembre 2016.

wsj.com (Global: 79^th place; Italian: 214^th place)

Chelsey Dulaney, Biogen Drops Idec From Name, su Wall Street Journal, 23 marzo 2015. URL consultato il 23 marzo 2015.
Charley Grant, Surprise Drug Approval Is Holiday Gift for Biogen, in Wall Street Journal, 27 dicembre 2016, ISSN 0099-9660 (WC · ACNP). URL consultato il 27 dicembre 2016.

Biogen (Italian Wikipedia)

archive.is (Global: 87th place; Italian: low place)

archive.today (Global: 14th place; Italian: 11th place)

biogen.com (Global: low place; Italian: low place)

investors.biogen.com

media.biogen.com

biopharmadive.com (Global: low place; Italian: low place)

bioprocessintl.com (Global: low place; Italian: low place)

biospace.com (Global: low place; Italian: low place)

bloomberg.com (Global: 99th place; Italian: 274th place)

boston25news.com (Global: low place; Italian: low place)

bostonglobe.com (Global: 553rd place; Italian: 1,614th place)

businessinsider.com (Global: 140th place; Italian: 340th place)

businesswire.com (Global: 615th place; Italian: 1,092nd place)

cbslocal.com (Global: 680th place; Italian: 1,804th place)

boston.cbslocal.com

centerforbiosimilars.com (Global: low place; Italian: low place)

cnbc.com (Global: 220th place; Italian: 646th place)

cnn.com (Global: 28th place; Italian: 84th place)

doi.org (Global: 2nd place; Italian: 7th place)

dx.doi.org

fda.gov (Global: 447th place; Italian: 644th place)

fda.gov

accessdata.fda.gov

fiercebiotech.com (Global: low place; Italian: low place)

fiercehealthcare.com (Global: low place; Italian: low place)

fiercepharma.com (Global: low place; Italian: low place)

firstwordpharma.com (Global: low place; Italian: low place)

fool.com (Global: 4,183rd place; Italian: 4,832nd place)

forbes.com (Global: 54th place; Italian: 97th place)

ft.com (Global: 210th place; Italian: 438th place)

markets.ft.com

genengnews.com (Global: low place; Italian: low place)

go.com (Global: 48th place; Italian: 166th place)

abcnews.go.com

ionispharma.com (Global: low place; Italian: low place)

ir.ionispharma.com

macrotrends.net (Global: 5,641st place; Italian: 6,632nd place)

miamitimesonline.com (Global: low place; Italian: low place)

mstrust.org.uk (Global: low place; Italian: low place)

multiple-sclerosis-research.blogspot.com (Global: low place; Italian: low place)

nasdaq.com (Global: 2,740th place; Italian: 3,855th place)

nationalmssociety.org (Global: low place; Italian: low place)

nbcboston.com (Global: low place; Italian: 5,570th place)

nobelprize.org (Global: 301st place; Italian: 270th place)

nytimes.com (Global: 7th place; Italian: 19th place)

nzz.ch (Global: 687th place; Italian: 2,894th place)

pharmatimes.com (Global: low place; Italian: low place)

reuters.com (Global: 49th place; Italian: 129th place)

sciencemag.org (Global: 857th place; Italian: 540th place)

sec.gov (Global: 572nd place; Italian: 1,269th place)

statista.com (Global: 776th place; Italian: 1,107th place)

statnews.com (Global: 8,771st place; Italian: low place)

thepharmaletter.com (Global: low place; Italian: low place)

tmx.com (Global: low place; Italian: low place)

money.tmx.com

uci.edu (Global: 3,063rd place; Italian: 5,968th place)

mind.uci.edu

ucsd.edu (Global: 1,933rd place; Italian: 4,694th place)

libraries.ucsd.edu

unibo.it (Global: 4,963rd place; Italian: 325th place)

acnpsearch.unibo.it

wbur.org (Global: 2,911th place; Italian: low place)

wcvb.com (Global: low place; Italian: low place)

web.archive.org (Global: 1st place; Italian: 1st place)

worldcat.org (Global: 5th place; Italian: 26th place)

wsj.com (Global: 79th place; Italian: 214th place)

archive.is (Global: 87^th place; Italian: low place)

archive.today (Global: 14^th place; Italian: 11^th place)

bloomberg.com (Global: 99^th place; Italian: 274^th place)

bostonglobe.com (Global: 553^rd place; Italian: 1,614^th place)

businessinsider.com (Global: 140^th place; Italian: 340^th place)

businesswire.com (Global: 615^th place; Italian: 1,092^nd place)

cbslocal.com (Global: 680^th place; Italian: 1,804^th place)

cnbc.com (Global: 220^th place; Italian: 646^th place)

cnn.com (Global: 28^th place; Italian: 84^th place)

doi.org (Global: 2^nd place; Italian: 7^th place)

fda.gov (Global: 447^th place; Italian: 644^th place)

fool.com (Global: 4,183^rd place; Italian: 4,832^nd place)

forbes.com (Global: 54^th place; Italian: 97^th place)

ft.com (Global: 210^th place; Italian: 438^th place)

go.com (Global: 48^th place; Italian: 166^th place)

macrotrends.net (Global: 5,641^st place; Italian: 6,632^nd place)

nasdaq.com (Global: 2,740^th place; Italian: 3,855^th place)

nbcboston.com (Global: low place; Italian: 5,570^th place)

nobelprize.org (Global: 301^st place; Italian: 270^th place)

nytimes.com (Global: 7^th place; Italian: 19^th place)

nzz.ch (Global: 687^th place; Italian: 2,894^th place)

reuters.com (Global: 49^th place; Italian: 129^th place)

sciencemag.org (Global: 857^th place; Italian: 540^th place)

sec.gov (Global: 572^nd place; Italian: 1,269^th place)

statista.com (Global: 776^th place; Italian: 1,107^th place)

statnews.com (Global: 8,771^st place; Italian: low place)

uci.edu (Global: 3,063^rd place; Italian: 5,968^th place)

ucsd.edu (Global: 1,933^rd place; Italian: 4,694^th place)

unibo.it (Global: 4,963^rd place; Italian: 325^th place)

wbur.org (Global: 2,911^th place; Italian: low place)

web.archive.org (Global: 1^st place; Italian: 1^st place)

worldcat.org (Global: 5^th place; Italian: 26^th place)

wsj.com (Global: 79^th place; Italian: 214^th place)